Norepinephrine Bitartrate Per recalls
The FDA has published 2 recalls involving Norepinephrine Bitartrate Per since 2022. The latest was reported on 30 Mar 2022. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2022
Last 12 months0reported
Class I00% of total
Ongoing0latest 30 Mar 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why norepinephrine bitartrate per is recalled
Companies
By year
All norepinephrine bitartrate per recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Norepinephrine Bitartrate Injection 4mg recalled | Athenex Pharma Solutions | Other | Nationwide |
| Drug | CLASS II | Norepinephrine Bitartrate Injection 8 mg recalled | Athenex Pharma Solutions | Other | Nationwide |
Should you stop taking Norepinephrine Bitartrate Per?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.